12-Tetradecanoylphorbol 13-acetate



Compound IDCDAMM01963
Common name12-Tetradecanoylphorbol 13-acetate
IUPAC name[13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate
Molecular formulaC36H56O8

Experimental data

Retention time16.65
Adduct[M+H]+
Actual mz617.401
Theoretical mz617.405
Error6.12
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.1315

Identifiers and class information

Inchi keyPHEDXBVPIONUQT-QQZQVUMWNA-N
SmilesO=C(OC12C(OC(=O)CCCCCCCCCCCCC)C(C)C3(O)C(C=C(CO)CC4(O)C(=O)C(=CC43)C)C1C2(C)C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)18
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)616.834
Computed dipole moment(dipole)2.659
Total solvent accessible surface area (SASA)1056.88
Hydrophobic component of SASA (FOSA)880.93
Hydrophilic component of SASA (FISA)158.782
Pie component of the SASA (PISA)17.169
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2046.57
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)9.2
Free energy of solvation of dipole (dip^2/V)0.0034557
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0150773
Globularity descriptor (glob)0.737605
Predicted polarizability in cubic angstroms (QPpolrz)64.356
Predicted hexadecane/gas partition coefficient (QPlogPC16)19.565
Predicted octanol/gas partition coefficient (QPlogPoct)30.278
Predicted water/gas partition coefficient (QPlogPw)12.945
Predicted octanol/water partition coefficient (QPlogPo/w)6.857
Predicted aqueous solubility (QPlogS)-8.8
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.812
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.86
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)309.154
Predicted brain/blood partition coefficient (QPlogBB)-2.467
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)139.088
Predicted skin permeability, log Kp (QPlogKp)-2.657
PM3 calculated ionization potential (IP(ev))9.339
PM3 calculated electron affinity (EA(eV))0.406
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)1.433
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)85.746
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)140.985
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P17612PRKACAcAMP-dependent protein kinase alpha-catalytic subunitT12808SEA
P24723PRKCHProtein kinase C etaT40149SEA
P05771PRKCBProtein kinase C betaT40276SEA
Q02156PRKCEProtein kinase C epsilonT00895SEA
Q13976PRKG1cGMP-dependent protein kinase 1 betaT78543SEA
Q04759PRKCQProtein kinase C thetaT23995SEA
P05129PRKCGProtein kinase C gammaT47107SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T12808DI0279Muscular atrophy[ICD-11: 8B61]P17612PRKACA
T40149DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]P24723PRKCH
T40276DI0123Diffuse large B-cell lymphoma[ICD-11: 2A81]P05771PRKCB
T40276DI0241Lymphoma[ICD-11: 2A80-2A86]P05771PRKCB
T40276DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P05771PRKCB
T00895DI0033Anxiety disorder[ICD-11: 6B00-6B0Z]Q02156PRKCE
T00895DI0243Malaria[ICD-11: 1F40-1F45]Q02156PRKCE
T23995DI0413Transplant rejection[ICD-11: NE84]Q04759PRKCQ
T47107DI0012Acute myeloid leukaemia[ICD-11: 2A60]P05129PRKCG
T47107DI0248Mastocytosis[ICD-11: 2A21]P05129PRKCG

Copyright © 2025